In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas ...
Large BIDMC-led study maps immune cells in myeloma tumors, improving risk prediction beyond genetics and helping identify ...
A peer-reviewed Harvard Medical School study recently published in Nature shows how a new artificial intelligence (AI) digital pathology tool called CHIEF (Clinical Histopathology Imaging Evaluation ...
SAN DIEGO, Sept. 2, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today provided an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results